Renal control of disease tolerance to malaria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30833408.
- Also identified by DOI 10.1073/pnas.1822024116 and PMC identifier 6431151.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria, the disease caused by <i>Plasmodium</i> spp. infection, remains a major global cause of morbidity and mortality. Host protection from malaria relies on immune-driven resistance mechanisms that kill <i>Plasmodium</i> However, these mechanisms are not sufficient per se to avoid the development of severe forms of disease. This is accomplished instead via the establishment of disease tolerance to malaria, a defense strategy that does not target <i>Plasmodium</i> directly. Here we demonstrate that the establishment of disease tolerance to malaria relies on a tissue damage-control mechanism that operates specifically in renal proximal tubule epithelial cells (RPTEC). This protective response relies on the induction of heme oxygenase-1 (<i>HMOX1</i>; HO-1) and ferritin H chain (<i>FTH</i>) via a mechanism that involves the transcription-factor nuclear-factor E2-related factor-2 (<i>NRF2</i>). As it accumulates in plasma and urine during the blood stage of <i>Plasmodium</i> infection, labile heme is detoxified in RPTEC by HO-1 and FTH, preventing the development of acute kidney injury, a clinical hallmark of severe malaria.
Medical subject headings
- Heme
- Kidney
- Malaria